A Gene-Based Classification of Primary Adrenocortical Hyperplasias

Abstract

Primary or adrenocorticotropin-independent adrenocortical tumors and hyperplasias represent a heterogeneous group of adrenocortical neoplasms that arise from various genetic defects, either in isolation or familial. The traditional classification as adenomas, hyperplasias, and carcinomas is non-specific. The recent identification of various germline and somatic genes in the development of primary adrenocortical hyperplasias has provided important new insights into the molecular pathogenesis of adrenal diseases. In this new era of personalized care and genetics, a gene-based classification that is more specific is required to assist in the understanding of their disease processes, hormonal functionality and signaling pathways. Additionally, a gene-based classification carries implications for treatment, genetic counseling and screening of asymptomatic family members. In this review, we discuss the genetics of benign adrenocorticotropin-independent adrenocortical hyperplasias, and propose a new gene-based classification system and diagnostic algorithm that may aid the clinician in prioritizing genetic testing, screening and counseling of affected, at risk individuals and their relatives.

Key words

adrenal hyperplasia - Cushing syndrome - genetics - Carney complex - cyclic AMP - PPNAD - PMAH

• References

• 1 Bimpaki EI, Nesterova M, Stratakis CA. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. Eur J Endocrinol 2009; 161: 153-161
• 2 Stratakis CA, Boikos SA. Genetics of adrenal tumors associated with Cushingʼs syndrome: A new classification for bilateral adrenocortical hyperplasias. Nat Clin Pract Endocrinol Metab 2007; 3: 748-757
• 3 Stratakis CA. New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors. Mol Cell Endocrinol 2009; 300: 152-157
• 4 Stratakis CA. Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: The NIH studies. Horm Metab Res 2007; 39: 467-473
• 5 Carney JA, Young WF, Stratakis CA. Primary bimorphic adrenocortical disease: Cause of hypercortisolism in McCune-Albright syndrome. Am J Surg Pathol 2011; 35: 1311-1326
• 6 Boston BA, Mandel S, LaFranchi S. et al. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushingʼs syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 1994; 79: 890-893
• 7 Weinstein LS, Shenker A, Gejman PV. et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991; 325: 1688-1695
• 8 Forlino A, Vetro A, Garavelli L. et al. PRKACB and Carney complex. N Engl J Med 2014; 370: 1065-1067
• 9 Kirschner LS, Carney JA, Pack SD. et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000; 26: 89-92
• 10 Horvath A, Mericq V, Stratakis CA. Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N Engl J Med 2008; 358: 750-752
• 11 Choi M, Scholl UI, Yue P. et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 2011; 331: 768-772
• 12 Assie G, Libe R, Espiard S. et al. ARMC5 mutations in macronodular adrenal hyperplasia with Cushingʼs syndrome. N Engl J Med 2013; 369: 2105-2114
• 13 Taylor SS, Ilouz R, Zhang P. et al. Assembly of allosteric macromolecular switches: lessons from PKA. Nat Rev Mol Cell Biol 2012; 13: 646-658
• 14 Mochizuki Y, Park MK, Mori T. et al. The difference in autofluorescence features of lipofuscin between brain and adrenal. Zoolog Sci 1995; 12: 283-288
• 15 Stratakis CA. cAMP/PKA signaling Defects in tumors: Genetics and tissue-specific pluripotential cell-derived lesions in human and mouse. Mol Cell Endocrinol 2013; 371: 208-220
• 16 Zeiger MA, Nieman LK, Cutler GB. et al. Primary bilateral adrenocortical causes of Cushingʼs syndrome. Surgery 1991; 110: 1106-1115
• 17 Kirschner MA, Powell RD, Lipsett MB. Cushingʼs Syndrome: Nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab 1964; 24: 947-955
• 18 Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 1998; 30: 456-463
• 19 Alencar GA, Lerario AM, Nishi MY. et al. ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia. J Clin Endocrinol Metab 2014; 99: E1501-E1509
• 20 Louiset E, Duparc C, Young J. et al. Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia. N Engl J Med 2013; 369: 2115-2125
• 21 Lefebvre H, Duparc C, Chartrel N. et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushingʼs syndrome. J Clin Endocrinol Metab 2003; 88: 3035-3042
• 22 Hsiao HP, Kirschner LS, Bourdeau I. et al. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J Clin Endocrinol Metab 2009; 94: 2930-2937
• 23 Lieberman SA, Eccleshall TR, Feldman D. ACTH-independent massive bilateral adrenal disease (AIMBAD): A subtype of Cushingʼs syndrome with major diagnostic and therapeutic implications. Eur J Endocrinol 1994; 131: 67-73
• 24 Bourdeau I, Lampron A, Costa MH, Tadjine M, Lacroix A. Adrenocorticotropic hormone-independent Cushingʼs syndrome. Current opinion in endocrinology. diabetes, and obesity 2007; 14: 219-2125
• 25 Bourdeau I, DʼAmour P, Hamet P. et al. Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushingʼs syndrome. J Clin Endocrinol Metab 2001; 86: 5534-5540
• 26 Lacroix A, Bourdeau I, Lampron A. et al. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction. Clin Endocrinol 2010; 73: 1-15
• 27 Berthon A, Hannah-Shmouni F, Maria AG. et al. High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia. J Steroid Biochem Mol Biol 2019; 191: 105316
• 28 Hannah-Shmouni F, Moraitis AG, Romero VV. et al. Successful treatment of estrogen excess in primary bilateral macronodular adrenocortical hyperplasia with leuprolide acetate. Horm Metab Res 2018; 50: 124-132
• 29 Faucz FR, Zilbermint M, Lodish MB. et al. Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: A clinical and genetic investigation. J Clin Endocrinol Metab 2014; 99: E1113-E1119
• 30 Kyo C, Usui T, Kosugi R. et al. ARMC5 Alterations in Primary Macronodular Adrenal Hyperplasia (PMAH) and the Clinical State of Variant Carriers. J Endocr Soc 2019; 3: 1837-1846
• 31 Correa R, Zilbermint M, Berthon A. et al. The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia. Eur J Endocrinol 2015; 173: 435-440
• 32 Fragoso MC, Domenice S, Latronico AC. et al. Cushingʼs syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003; 88: 2147-2151
• 33 Rothenbuhler A, Horvath A, Libe R. et al. Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours. Clin Endocrinol (Oxf) 2012; 77: 195-199
• 34 Beuschlein F, Fassnacht M, Assie G. et al. Constitutive activation of PKA catalytic subunit in adrenal Cushingʼs syndrome. N Engl J Med 2014; 370: 1019-1028
• 35 Lodish MB, Yuan B, Levy I. et al. Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: Molecular mechanisms and clinical presentations. Eur J Endocrinol 2015; 172: 803-811
• 36 Swords FM, Baig A, Malchoff DM. et al. Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Mol Endocrinol 2002; 16: 2746-2753
• 37 Almeida MQ, Harran M, Bimpaki EI. et al. Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: Progression of tumorigenesis in a disorder associated with multiple benign lesions. J Clin Endocrinol Metab 2011; 96: E728-E738
• 38 Cao Y, He M, Gao Z. et al. Activating hotspot L205R mutation in PRKACA and adrenal Cushingʼs syndrome. Science 2014; 344: 913-917
• 39 Kirk JM, Brain CE, Carson DJ. et al. Cushingʼs syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr 1999; 134: 789-792
• 40 Benjamin DR, McRoberts JW. Polyostotic fibrous dysplasia associated with Cushing syndrome. Arch Pathol 1973; 96: 175-178
• 41 Paris F, Philibert P, Lumbroso S. et al. Isolated Cushingʼs syndrome: An unusual presentation of McCune-Albright syndrome in the neonatal period. Horm Res 2009; 72: 315-319
• 42 Gillis D, Rosler A, Hannon TS. et al. Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome. J Pediatr 2008; 152: 882-884 4 e1–4
• 43 Hamajima T, Maruwaka K, Homma K. et al. Unilateral adrenalectomy can be an alternative therapy for infantile onset Cushingʼ s syndrome caused by ACTH-independent macronodular adrenal hyperplasia with McCune-Albright syndrome. Endocr J 2010; 57: 819-824
• 44 Brown RJ, Kelly MH, Collins MT. Cushing syndrome in the McCune-Albright syndrome. J Clin Endocrinol Metab 2010; 95: 1508-1515
• 45 Lecoq AL, Stratakis CA, Viengchareun S. et al. Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushingʼs syndrome. JCI Insight 2017; 2: e92184
• 46 Schweizer-Cagianut M, Froesch ER, Hedinger C. Familial Cushingʼs syndrome with primary adrenocortical microadenomatosis (primary adrenocortical nodular dysplasia). Acta Endocrinol (Copenh) 1980; 94: 529-535
• 47 Shenoy BV, Carpenter PC, Carney JA. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol 1984; 8: 335-344
• 48 Stratakis CA, Carney JA, Lin JP. et al. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest 1996; 97: 699-705
• 49 Husebye ES, Allolio B, Arlt W. et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014; 275: 104-115
• 50 Gunther DF, Bourdeau I, Matyakhina L. et al. Cyclical Cushing syndrome presenting in infancy: An early form of primary pigmented nodular adrenocortical disease, or a new entity?. J Clin Endocrinol Metab 2004; 89: 3173-3182
• 51 Carney JA, Gaillard RC, Bertherat J. et al. Familial micronodular adrenocortical disease, Cushing syndrome, and mutations of the gene encoding phosphodiesterase 11A4 (PDE11A). Am J Surg Pathol 2010; 34: 547-555
• 52 Horvath A, Giatzakis C, Tsang K. et al. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: A novel PDE8B isoform in human adrenal cortex. Eur J Hum Genet 2008; 16: 1245-1253
• 53 Horvath A, Boikos S, Giatzakis C. et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 2006; 38: 794-800
• 54 Carney JA, Lyssikatos C, Lodish MB. et al. Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes. Hum Pathol 2015; 46: 40-49
• 55 Stratakis CA, Kirschner LS, Carney JA. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 2001; 86: 4041-4046
• 56 Horvath A, Bertherat J, Groussin L. et al. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): An update. Hum Mutat 2010; 31: 369-379
• 57 Chandrasekharappa SC, Guru SC, Manickam P. et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-407
• 58 Gatta-Cherifi B, Chabre O, Murat A. et al. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe dʼetude des Tumeurs Endocrines database. Eur J Endocrinol 2012; 166: 269-279
• 59 Matyakhina L, Freedman RJ, Bourdeau I. et al. Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: A clinical and molecular genetic investigation. J Clin Endocrinol Metab 2005; 90: 3773-3779
• 60 Lehtonen HJ, Kiuru M, Ylisaukko-Oja SK. et al. Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 2006; 43: 523-526
• 61 Haller F, Moskalev EA, Faucz FR. et al. Aberrant DNA hypermethylation of SDHC: A novel mechanism of tumor development in Carney triad. Endocr Relat Cancer 2014; 21: 567-577
• 62 Carney JA, Sheps SG, Go VL. et al. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. N Engl J Med 1977; 296: 1517-1518
• 63 Carney JA, Stratakis CA, Young WF. Adrenal cortical adenoma: the fourth component of the Carney triad and an association with subclinical Cushing syndrome. Am J Surg Pathol 2013; 37: 1140-1149
• 64 Raygada M, King KS, Adams KT. et al. Counseling patients with succinate dehydrogenase subunit defects: Genetics, preventive guidelines, and dealing with uncertainty. J Pediatr Endocrinol Metab 2014; 27: 837-844